Search Within

Sujata Patil

Formats
  1. Meeting Abstract (278)
  2. Journal Article (230)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Biostatistics Service (511)
  2. Epidemiology and Biostatistics (511)
  3. Department of Medicine (363)
  4. Solid Tumor Oncology Division (358)
  5. Survivorship Research (323)
  6. Surgery (247)

More Groups

People
  1. Clifford Hudis (141)
  2. Larry Norton (97)
  3. Robert Motzer (93)
  4. Monica Morrow (83)
  5. Darren Feldman (81)
  6. Edi Brogi (65)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (24)
  5. 2020 (29)
  6. 2019 (31)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Annals of Surgical Oncology (67)
  3. Cancer Research (55)
  4. Cancer (23)
  5. Breast Cancer Research and Treatment (18)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (172)
  2. Springer (92)
  3. American Association for Cancer Research (71)
  4. Elsevier Inc. (34)
  5. Wiley Blackwell (33)
  6. Oxford University Press (19)

More Publishers

Results (511)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular classification of sunitinib response in metastatic renal cell carcinoma (mRCC) patients by gene expression profiling
    Meeting Abstract

    Thodima, V. J.; Molina, A. M.; Jia, X.; Zhang, J.; Georges, M. E.; Patil, S.; Reuter, V. E.; Motzer, R. J.; Chaganti, R. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Does metformin use influence outcome in diabetic women with invasive breast cancer?
    Meeting Abstract

    Oppong, B.; Oskar, S.; Stempel, M.; Eaton, A.; Patil, S.; King, T. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk factor migration and survival: Analysis from international dataset of 3,748 metastatic renal cell carcinoma (mRCC) patients treated on clinical trials
    Meeting Abstract

    Patil, S.; Manola, J.; Elson, P.; Bro, W.; Negrier, S.; Escudier, B.; Bukowski, R. M.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term response to sunitinib for metastatic renal cell carcinoma (mRCC) patients treated on clinical trials at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Molina, A. M.; Jia, X.; Ginsberg, M. S.; Velasco, S.; Feldman, D. R.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Standardized uptake value (SUV) by positron emission tomography/computed tomography (PET/CT) as a prognostic variable in metastatic breast cancer (MBC)
    Meeting Abstract

    Morris, P. G.; Fazio, M.; Jhaveri, K. L.; Serna-Tamayo, C.; Eaton, A.; Patil, S.; Ulaner, G.; Howard, J.; Larson, S. M.; Hudis, C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Risk of breast cancer (BC) after BRCA-mutation associated ovarian cancer (BRCA-OC): Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Jhaveri, K. L.; Patil, S.; Khasraw, M.; Bhatia, J.; Stadler, Z. K.; Kauff, N. D.; Hudis, C.; Offit, K.; Robson, M. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
    Meeting Abstract

    Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Molina, A. M.; Feldman, D. R.; Ginsberg, M. S.; Fischer, P.; Trinos, M. J.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save